• New in the Library

    New in the Library (November-December 2024)

    Here are the latest items added to the CTN Dissemination Library for November-December 2024 (this post will be updated as new items come in): Factors Associated with PrEP Awareness and Use Among Men Who Have Sex with Men Who Use Drugs in the Southern United States. Paschen-Wolff M, et al. AIDS Care 2024 (in press). (CTN-0082) Efficient and Flexible Mediation Analysis with Time-Varying Mediator, Treatments, and Confounders. Díaz I, Journal of Causal Inference 2023;11(1):20220077. (CTN-0051) Pharmacy-Based Preventive Services for Opioid Use Disorder: A Survey of U.S. Pharmacists. Wu L, et al. Addiction Science & Clinical Practice 2024;19:88. (primary outcomes for CTN-0105) CTN-0138: Adaptation, Implementation, and Cluster Randomized Trial of a Community Pharmacy-Based…

  • New in the Library

    New in the Library (October-November 2024)

    Here are the latest items added to the CTN Dissemination Library for October-November 2024 (this post will be updated as new items come in): Machine Learning-Driven Analysis of Individualized Treatment Effects Comparing Buprenorphine and Naltrexone in Opioid Use Disorder Relapse Prevention. Afshar M, et al. Journal of Addiction Medicine 2024;18(5):511-519. (CTN-0051) Variation in Opioid Agonist Dosing in Clinical Trials by Race and Ethnicity. Ross RK, et al. JAMA Network Open 2024;7(10):e2436612. Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment. Nunes EV, et al. American Journal of Psychiatry 2021;178(7):660-671. (CTN-0051) Examination of Correlates of OUD Outcomes in Young Adults:…

  • New in the Library

    New in the Library (September-October 2024)

    Here are the latest items added to the CTN Dissemination Library for September– October 2024 (this post will be updated as new items come in): Falling Through the Cracks: The Struggle of Adolescents with Opioid Use Disorder in the Face of Limited Treatment Options. Kaliamurty S. Youth Special Interest Group (SIG) webinar, September 2024. Changes in Prenatal Cannabis Use Among Pregnant Individuals From 2012 to 2022. Young-Wolff KC, et al. Obstetrics & Gynecology 2024;144(4):e101-e104. Effectiveness of a Vaping Cessation Text Message Program Among a Diverse and High-Risk Sample of Adolescent E-Cigarette Users (webinar recording). Graham AL. Youth Special Interest Group (SIG) webinar, September 2024. Peer Intervention to Link Overdose Survivors…

  • New in the Library

    New in the Library (July – August 2024)

    Here are the latest items added to the CTN Dissemination Library for July – August 2024 (this post will be updated as new items come in): Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool in Screening Older Adults for Unhealthy Substance Use. Han BH, et al. Journal of Addiction Medicine 2024 (in press). (CTN-0059) Analyzing Quality of Life Among People with Opioid Use Disorder from the National Institute on Drug Abuse Data Share Initiative: Implications for Decision Making. Patton T, et al. Quality of Life Research 2024 (in press). (multiple protocols) Delivering MOUD to the Underserved: How Can Pharmacies Really Help? Gustafson DH, et al.…

  • Primary Outcomes Paper for CTN-0124: Delivering MOUD to the Underserved: How Can Pharmacies Really Help?

    The primary outcomes paper for CTN-0124, Assessment and Design of a Cost-Effective Collaborative MOUD Delivery System, is now available! Citation: Gustafson DH, Molfenter T, Kunes T, Langdon L, Koplin M, Parker F, Branny K, Ghitza U, Bart G. Delivering MOUD to the Underserved: How Can Pharmacies Really Help? Journal of Studies on Alcohol and Drugs 2024 (in press). What’s the question? Access to treatment for opioid use disorder (OUD) is a challenge in rural settings and for communities of color, partly because of the limited availability of healthcare providers equipped and willing to provide medications for OUD (MOUD). Pharmacies have been increasingly proposed as one way to enhance access to…

  • New in the Library

    New in the Library (June – July 2024)

    Here are the latest items added to the CTN Dissemination Library for June – July 2024 (this post will be updated as new items come in): Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal. D’Onofrio G, et al. JAMA Network Open 2024;7(7):e2420702. The Potential Impact of Clinical Decision Support on Nonwaivered Primary Care Clinicians’ Prescribing of Buprenorphine. Olson AW, et al. Health Affairs Scholar 2023;1(4):qxad051. CTN-0076-Ot Barriers and Facilitators to Using a Clinical Decision Support Tool for Opioid Use Disorder in Primary Care: Insights from Clinicians and Clinic Leaders. Hooker SA, et al. Journal of the American Board of Family Medicine 2024 (in press). CTN-0076-Ot Assessing…

  • New in the Library

    New in the Library (May – June 2024)

    Here are the latest items added to the CTN Dissemination Library for May – June 2024 (this post will be updated as new items come in): “To prescribe or not to prescribe, that is the question”: Perspectives on opioid prescribing for chronic, cancer-related pain from clinicians who treat pain in survivorship. Bulls HW, et al. Cancer. 2024 Apr 3. doi: 10.1002/cncr.35299. PMID: 38567685. CTN-0115 Substance Use Among Black Adolescents – Maximizing Strengths and Overcoming Barriers in Substance Use Prevention. Aneni K. Youth Special Interest Group (SIG) webinar, May 2024. Wiidookaage’win: Beta-test of a Facebook Group Intervention for Native Women to Support Opioid Use Recovery. Roche AI, et al. Journal of…

  • Protocol Update

    Update on CTN-0097: Primary Outcomes Article Published!

    The primary outcomes article for CTN-0097, Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): Improving the Real-World Effectiveness of Injection Naltrexone for Opioid Use Disorder (NIH HEAL Initiative), is now available! Published in JAMA Network Open, the findings from the study suggest that starting people with opioid use disorder (OUD) on extended-release injectable naltrexone (XR-naltrexone) within 5-7 days of seeking treatment is more effective than the standard treatment method of starting within 10-15 days, but requires closer medical supervision. This rapid treatment protocol could make XR-naltrexone more viable as a treatment option for OUD, as the longer waiting period was a significant barrier to implementation of XR-naltrexone for many…

  • New in the Library

    New in the Library (Apr – May 2024)

    ATTENTION! The new CTN Directory is here! Published in April 2024, it has updated contact information for members of all 16 nodes, the Clinical Coordinating Center, and the Data and Statistics Center. You can find a link to it right on the CTN Dissemination Library’s home page as well as RIGHT HERE. Here are the latest items added to the CTN Dissemination Library for April – May 2024 (this post will be updated as new items come in): Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial. Shulman M, et al. JAMA Network Open 2024;7(5):e249744. Primary Outcomes Article for CTN-0097 Empirically Contrasting Urine Drug…

  • New in the Library

    New in the Library (Mar – Apr 2024)

    ATTENTION! The new CTN Directory is here! Published in April 2024, it has updated contact information for members of all 16 nodes, the Clinical Coordinating Center, and the Data and Statistics Center. You can find a link to it right on the CTN Dissemination Library’s home page as well as RIGHT HERE. Here are the latest items added to the CTN Dissemination Library for March – April 2024 (this post will be updated as new items come in):  Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): Protocol for CTN-0098B A Randomized Implementation Study to Support Hospitals in Caring for Patients with Opioid Use Disorder. Bart G, et al.…